These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8402308)

  • 1. Evaluation of screening for cancer.
    Chamberlain J
    Community Dent Health; 1993 Jun; 10 Suppl 1():5-11. PubMed ID: 8402308
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program.
    Hamashima C; Sobue T; Muramatsu Y; Saito H; Moriyama N; Kakizoe T
    Jpn J Clin Oncol; 2006 May; 36(5):301-8. PubMed ID: 16735372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of cancer.
    Champion VL; Rawl SM
    Semin Oncol Nurs; 2005 Nov; 21(4):252-9. PubMed ID: 16293513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of histopathologic diagnoses in a cancer registry].
    Staszewski J; Niepolomska W
    Pol Tyg Lek; 1969 Dec; 24(50):1936-8. PubMed ID: 5367079
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer screening: overview and prospects.
    Berkel HJ
    J La State Med Soc; 1996 May; 148(5):219-25. PubMed ID: 8775379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theoretical conditions for cancer screening. Example of prostate cancer].
    Irani J
    Prog Urol; 1999 Jun; 9(3):435-9. PubMed ID: 10434314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy screened bias in epidemiologic studies of cancer incidence.
    Weiss NS; Rossing MA
    Epidemiology; 1996 May; 7(3):319-22. PubMed ID: 8728451
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges to cancer control by screening.
    Pollak MN; Foulkes WD
    Nat Rev Cancer; 2003 Apr; 3(4):297-303. PubMed ID: 12671668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer screening].
    Akaza H; Tsuruo T; Saijo N; Sone S; Isonishi S; Ohashi Y; Sobue T; Yamanaka H; Fukuda M; Maruyama M; Eguchi K; Ito K; Smith M; Milsted B
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):125-34. PubMed ID: 15675598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening].
    Durand-Zaleski I; Bastuji-Garin S
    Rev Prat; 2000 May; 50(10):1155-8. PubMed ID: 10905104
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiologic evaluation of early detection measures in cancer].
    Wahrendorf J
    Fortschr Med; 1988 Mar; 106(9):171-3. PubMed ID: 3371831
    [No Abstract]   [Full Text] [Related]  

  • 12. Principles of cancer prevention and early detection.
    Mahon SM
    Clin J Oncol Nurs; 2000; 4(4):169-76. PubMed ID: 11261098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer prevention and screening: do they make a difference?
    Taylor BD
    Ethn Dis; 2002; 12(1):S2-60-2. PubMed ID: 11913648
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer screening and informed patient discussions. Truth and consequences.
    Wolf AM; Becker DM
    Arch Intern Med; 1996 May; 156(10):1069-72. PubMed ID: 8638993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New criteria for detecting occult hemorrhage in screening for colorectal cancer].
    Ottó S
    Orv Hetil; 2001 Jul; 142(29):1541-5. PubMed ID: 11494745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer screening: an educational challenge?
    Moore MA; Tsuda H
    Eur J Cancer Prev; 1999 Feb; 8(1):7-16. PubMed ID: 10091038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group.
    Straatman H; Peer PG; Verbeek AL
    Biometrics; 1997 Mar; 53(1):217-29. PubMed ID: 9147591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of satisfaction with cancer screening at mobile van and static sites: National Cancer Screening Program in Korea.
    Yoon NH; Lee HY; Kwak MS; Choi KS; Jun JK; Kim MK; Park EC
    Jpn J Clin Oncol; 2009 Mar; 39(3):169-74. PubMed ID: 19179364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.
    Kobayashi T; Goto R; Fukui T; Ogawa O
    Int J Urol; 2007 Sep; 14(9):805-10. PubMed ID: 17760746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.